Having trouble viewing this e-mail? CLICK HERE
BioPharm
February 2018
Volume 31, No. 2
VIEW ONLINE ARCHIVE SUBSCRIBE FORWARD LinkedIn LinkedIn

| COVER STORY |

The Ins and Outs of LC-Based Analytical Tools and Techniques

Anne Blackwell, PhD

The critical quality attributes of biotherapeutics must be monitored to ensure product safety and efficacy.
read more


| IMPURITY TESTING |

Impurity Testing of Biologic Drug Products

Adeline Siew, PhD

Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
read more

BioPharm International February Issue
Download on the app store Read the issue online Subscribe or renew your BioPharm subscription subscribe

| ANALYTICS: DATA INTEGRITY |

Maintaining Lab Data Integrity

Amber Lowry

This article explores lab data integrity violation trends, as well as a sampling of the latest technologies that can help avoid them.
read more


| QUALITY |

Preclinical Evaluation of Product Related Impurities and Variants

Anurag S. Rathore, Dinesh K. Yadav, Shyam S. Pandey, Sumit K. Singh, Deepak Kumar

The approaches for sample preparation of preclinical evaluation of safety and efficacy are addressed taking into consideration the shortcoming with the contemporary approaches.
read more


| DOWNSTREAM PROCESSING |

Industry Adoption of Single-Use Systems Remains Low

Feliza Mirasol

Single-use technologies are starting to gain ground as capacity needs change, but industrywide adoption remains low.
read more


| CELL AND GENE THERAPY MANUFACTURING |

FDA Framework Spurs Advanced Therapies

Cynthia A. Challener

Clarity on the application of existing regulations will accelerate development of cell and gene therapies.
read more


| FACILITY DESIGN AND OPERATIONS |

Designing a Single-Use Biopharmaceutical Process

Jennifer Markarian

Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.
read more


| CONTAINER CLOSURES |

Container Closures: Leaving Nothing to Chance

Agnes Shanley

As closure integrity testing moves from a probabilistic to a deterministic basis, designs are promoting improved control and reduced operator contact.
read more


| FROM THE EDITOR |

A New Business Model for Pharma?

Rita C. Peters

Frustrated with high costs and drug shortages, hospitals adopt a DIY approach.
read more


| REGULATORY BEAT |

Opportunities and Obstacles for Generic Drugs

Jill Wechsler

Manufacturers tackle regulatory and competitive issues to develop complex therapies and biosimilars.
read more


| ASK THE EXPERT |

Applying GMPs in Stages of Development

Susan J. Schniepp

Regardless of the phase of development and the level of GMPs being applied, there should be adequate controls and knowledge to assure patient safety.
read more


UPCOMING WEBCAST

Analytics in Support of Cell Line Development, Tailored Modulations, and Downstream Processing Using a Single Biopharmaceutical Platform Solution
Live Webcast: Tuesday, February 13 at 10:00am EST
Register now


| EVENTS |

IFPAC-2018

Feb. 11–14, 2018

Pittcon 2018

Feb. 26–Mar. 1, 2018

9th Global Drug Delivery & Formulation Summit

Mar. 12–14, 2018

Paperless Lab Academy 2018

Mar. 12–14, 2018


more events

Contribute an article | contact the editors | contact sales | subscribe | advertise